Autoimmune bullous diseases : text and review / Barbara Horváth, editor.

This extensively revised new edition provides a quick study and reference guide for physicians who treat patients with autoimmune bullous diseases (AIBDs), the most life-threatening inflammatory diseases of the skin. AIBDs are rare, comprising less than 1% of the dermatological patients and as such,...

Full description

Saved in:
Bibliographic Details
Other Authors: Horváth, Barbara (Editor)
Format: eBook
Language:English
Published: Cham : Springer, [2022]
Edition:Second edition.
Subjects:
Online Access:Click for online access
Description
Summary:This extensively revised new edition provides a quick study and reference guide for physicians who treat patients with autoimmune bullous diseases (AIBDs), the most life-threatening inflammatory diseases of the skin. AIBDs are rare, comprising less than 1% of the dermatological patients and as such, they are often given little focus in general dermatology literature, despite being complicated and demanding diseases to manage. Chapters cover the latest developments in diagnostic assays and the use of pemphigoids. New contributions include how AIBD affects children and the care of wounds in instances of blistering disease from the perspective of a nurse practitioner. Autoimmune Bullous Diseases: Text and Review is written in a direct and simple style with tables and figures to illustrate this difficult field practically. At the end of each chapter the reader is challenged to check the learned matter with multiple-choice questions, while it contains protocols and follows international guidelines, making it suitable study material for courses on autoimmune bullous diseases. Residents and researchers in dermatology and adjacent disciplines will find this book useful as a quick guide when dealing with these patients.
Item Description:Includes index.
Physical Description:1 online resource : color illustrations
ISBN:9783030915575
3030915573
Source of Description, Etc. Note:Online resource; title from PDF title page (SpringerLink, viewed January 28, 2022).